drugset / Trial / NCT01734889

Taste and Palatability of Orfadin Suspension

NCT01734889

Phase 1 Completed 18 enrolled Swedish Orphan Biovitrum
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to verify that pediatric patients, especially those who are not old enough to swallow capsules, accept the taste and palatability of a new suspension.

Timeline

Start
2012-10
Primary completion
2013-03
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitisinone Small molecule Oral

Indications